Will you be attending DIA China this year? Welcome to visit our booth #C3B19.
George Clinical has provided full-service clinical trial solutions in China since 2007 with therapeutic expertise in kidney and metabolic, oncology, cardiovascular, neurology and respiratory.
Are you looking for assistance on an upcoming project? George Clinical’s CEO, James Cheong, and Regional Head Project Operations, China, Zhenfei Yin, will attend the summit with the China team. Our people will help answer your questions, including questions about our global service capabilities and Phase I trial experience in Australia.
For more information or to schedule a convenient meeting time, please contact our Head of Business Development, APAC, Fred Li.
The goal of DIA China 2023 Annual Meeting is to amplify different voices, highlight expertise across the world, bring together experts to empower breakthroughs in life sciences, protect patients’ well-being and build the healthcare ecosystem of the future.
Hope to see you there!
With over three decades of experience, Dr Gunn has held pivotal roles in leading biotech firms and academic institutions including Pfizer, Crucell (Johnson & Johnson), Becton Dickson, Clintec (IQVIA), ICON, and Health Decisions (Premier Research). She is a corporate strategy expert with extensive experience in life science corporate development, strategic partnerships, co-development, licensing partnerships, M&A and post-merger integrations. She is renowned for her extensive contributions to medical research, innovative drug development, contract research and clinical trials, and has spearheaded the development of several FDA-approved drugs, particularly in the CNS and vaccines domains. She is passionate about market access to innovation.
As Country Head, China, Zhenfei is responsible for leading the operations teams across China. Zhenfei Yin brings with him more than 17 years of substantial industry experience leading Project Management, Clinical Operations, and Business Development teams across the CRO and Pharmaceutical sectors. Before joining George Clinical as China country head, he worked in several global CROs and pharmaceuticals, including ICON, Wuxi AppTec, IQVIA, and Sanofi. His successfully led team completed more than 120 Phase I – IV clinical trials, most of which are global studies (Asia Pacific, Australia and the United States), covering different Therapeutic Area, including: Oncology, Cardiovascular, Central nervous system, Endocrine, Infectious diseases, Urology, Respiratory diseases, and medical devices/IVDs. He has Master Degree of Urology from Peking University 1st Hospital.
Suzhou, China
Meet with George Clinical! Contact us to schedule a time now.
